Effect of a Short-Course Treatment with Synbiotics on Plasma p-Cresol Concentration in Kidney Transplant Recipients

Journal of the American College of Nutrition

Volumn 36, Issue 7, 2017, Pages 586-591

  Guida, Bruna ^a,b   Cataldi, Mauro ^a,b   Memoli, Andrea ^a,b   Trio, Rossella ^b   di Maro, Martina ^a,b   Grumetto, Lucia ^a   Capuano, Ivana ^a,b   Federico, Stefano ^a,b   Pisani, Antonio ^a,b   Sabbatini, Massimo ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

kidney transplantation; p Cresol; Prebiotic; probiotic; synbiotic; uremic toxins

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; EVEROLIMUS; MYCOPHENOLIC ACID; PARA CRESOL; SYNBIOTIC AGENT; TACROLIMUS; 4-CRESOL; CRESOL; PREBIOTIC AGENT; PROBIOTIC AGENT;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHELOMETRY; NUTRITIONAL ASSESSMENT; PILOT STUDY; PROTEIN INTAKE; SHORT COURSE THERAPY; WAIST CIRCUMFERENCE; BLOOD; INTESTINE FLORA; ITALY; KIDNEY; KIDNEY DISEASE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; CRESOLS; DOUBLE-BLIND METHOD; GASTROINTESTINAL MICROBIOME; HUMANS; ITALY; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; PREBIOTICS; PROBIOTICS; SYNBIOTICS; TREATMENT OUTCOME;

EID: 85029404783     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2017.1334602     Document Type: Article

References (53)

1. Evenepoel P, Meijers BK, Bammens BR, Verbeke K, : Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl 114:S12–S19, 2009.
2. Schreiner G, Maher J, : “Uremia: The Biochemistry, Pathogenesis and Treatment.” Springfield, MA: Charles Thomas, 1960.
3. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W, and the European Uremic Toxin Work Group (EUTox): Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934–1943, 2003.
4. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G, : Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci U S A 106:3698–3703, 2009.
5. Scheline RR, : Metabolism of phenolic acids by rat intestinal microflora. Acta Pharmacol Toxicol (Copenh) 26:189–205, 1968.
6. Vanholder R, Bammens B, de Loor H, Glorieux G, Meijers B, Schepers E, Massy Z, Evenepoel P, : Warning: the unfortunate end of p-Cresol as a uraemic toxin. Nephrol Dial Transpl 26:1464–1467, 2011.
7. Sirich TL, Meyer TW, Gondouin B, Brunet P, Niwa T, : Protein-bound molecules: a large family with a bad character. Semin Nephrol 34:106–117, 2014.
8. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F, : Elevation of circulating endothelial microparticles in patients with chronic renal failure. J. Thromb. Haemost 4:566–573, 2006.
9. Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P, : Free p-Cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73:1174–1180, 2008.
10. Meijers BK, Van Kerckhoven S, Verbeke K, Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P, : The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54:891–901, 2009.
11. Meijers BK, Claes K, Bammens B, de Loor H, Viaene L, Verbeke K, Kuypers D, Vanrenterghem Y, Evenepoel P, : p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin J Am Soc Nephrol 5:1182–1189, 2010.
12. Schepers E, Meert N, Glorieux G, Goeman J, Van der Eycken J, Vanholder R, : p-cresylsulphate, the main in vivo metabolite of p-Cresol, activates leucocyte free radical production. Nephrol Dial Transplant 22:592–596, 2007.
13. Shafi T, Meyer TW, Hostetter TH, Melamed ML, Parekh RS, Hwang S, Banerjee T, Coresh J, Powe NR, : Free levels of selected organic solutes and cardiovascular morbidity and mortality in hemodialysis patients: results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators. PLoS One 10:e0126048, 2015.
14. Brocca A, Virzì GM, de Cal M, Cantaluppi V, Ronco C, : Cytotoxic effects of p-Cresol in renal epithelial tubular cells. Blood Purif 36:219–225, 2013.
15. Watanabe H, Miyamoto Y, Honda D, Tanaka H, Wu Q, Endo M, Noguchi T, Kadowaki D, Ishima Y, Kotani S, Nakajima M, Kataoka K, Kim-Mitsuyama S, Tanaka M, Fukagawa M, Otagiri M, Maruyama T, : p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase. Kidney Int 83:582–592, 2013.
16. Sun CY, Chang SC, Wu MS, : Uremic toxins induce kidney fibrosis by activating intrarenal renin–angiotensin–aldosterone system associated epithelial-to-mesenchymal transition. PLoS One 7:e34026, 2012.
17. Sun CY, Hsu HH, Wu MS, : p-Cresol sulfate and indoxyl sulfate induce similar cellular inflammatory gene expressions in cultured proximal renal tubular cells. Nephrol Dial Transplant 28:70–78, 2013.
18. Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, Wu MS, : Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients—a prospective cohort study. Nephrol Dial Transplant 27:1169–1175, 2012.
19. Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y, : Free serum concentrations of the protein-bound retention solute p-Cresol predict mortality in hemodialysis patients. Kidney Int 69:1081–1087, 2006.
20. Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P, : Free p-Cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73:1174–1180, 2008.
21. Poesen R, Viaene L, Verbeke K, Augustijns P, Bammens B, Claes K, Kuypers D, Evenepoel P, Meijers B, : Cardiovascular disease relates to intestinal uptake of p-Cresol in patients with chronic kidney disease. BMC Nephrol 15:87, 2014.
22. Huang ST, Shu KH, Cheng CH, Wu MJ, Yu TM, Chuang YW, Chen CH, : Serum total p-Cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients. Transplant Proc 44:621–624, 2012.
23. Ligabue G, Damiano F, Cuoghi A, De Biasi S, Bellei E, Granito M, Aldo T, Cossarizza A, Cappelli G, : p-Cresol and cardiovascular risk in kidney transplant recipients. Transplant Proc 47:2121–2125, 2015.
24. Arend SM, Mallat MJ, Westendorp RJ, van der Woude FJ, van Es LA, : Patient survival after renal transplantation: more than 25 years follow-up. Nephrol Dial Transplant 12:1672–1679, 1997.
25. Fazelzadeh A, Mehdizadeh A, Ostovan MA, Raiss-Jalali GA, : Incidence of cardiovascular risk factors and complications before and after kidney transplantation. Transplant Proc 38:506–508, 2006.
26. U.S. Renal Data System: “USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States.” Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2007.
27. Kasiske B, Chakkera H, Roel J, : Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11:1735–1743, 2000.
28. De Smet R, Glorieux G, Vanholder R, : p-Cresol and uric acid: two old uremic toxins revisited. Kidney Int Suppl 62:S8–S11, 1997.
29. Gibson GR, Scott KP, Rastall RA, Buddington RK, : Dietary prebiotics: current status and new definition. Food Sci Technol Bull 7:1–19, 2010.
30. Nakabayashi I, Nakamura M, Kawakami K, Ohta T, Kato I, Uchida K, Yoshida M, : Effects of synbiotic treatment on serum level of p-Cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant 26:1094–1098, 2011.
31. Guida B, Germanò R, Trio R, Russo D, Memoli B, Grumetto L, Barbato F, Cataldi M, : Effect of short-term synbiotic treatment on plasma p-Cresol levels in patients with chronic renal failure: a randomized clinical trial. Nutr Metab Cardiovasc Dis 24:1043–1049, 2014.
32. Dumville JC, Hahn S, Miles JN, Torgerson DJ, : The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials 27:1–12, 2006.
33. Guida B, Cataldi M, Maresca ID, Germanò R, Trio R, Nastasi AM, Federico S, Memoli A, Apicella L, Memoli B, Sabbatini M, : Dietary intake as a link between obesity, systemic inflammation, and the assumption of multiple cardiovascular and antidiabetic drugs in renal transplant recipients. Biomed Res Int 2013:363728, 2013.
34. Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D, : Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 61(Suppl):1402S–1406S, 1995.
35. National Kidney Foundation: “K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure.” New York: National Kidney Foundation, 2001.
36. Greater Metropolitan Clinical Taskforce (Renal Services Network): “Evidence-Based Guidelines for the Nutritional Management of Adult Kidney Transplant Recipients.” Sydney: Greater Metropolitan Clinical Taskforce (Renal Services Network), 2008.
37. Kasiske B, Cosio FG, Beto J, Bolton K, Chavers BM, Grimm R, Jr, Levin A, Masri B, Parekh R, Wanner C, Wheeler DC, Wilson PW, and the National Kidney Foundation: Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant 4(Suppl 7):13–53, 2004.
38. Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, Sampson L, Willett WC, : Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 69:243–249, 1999.
39. Guida B, Napoleone A, Trio R, Nastasi A, Balato N, Laccetti R, Cataldi M, : Energy restricted, n-3 polyunsaturated fatty acids–rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial. Clin Nutr 33:399–405, 2014.
40. Guida B, Cataldi M, Riccio E, Grumetto L, Pota A, Borrelli S, Memoli A, Barbato F, Argentino G, Salerno G, Memoli B, : Plasma p-Cresol lowering effect of sevelamer in peritoneal dialysis patients: evidence from a cross-sectional observational study. PLoS One 8:e73558, 2013.
41. Lin CJ, Chen HH, Pan CF, Chuang CK, Wang TJ, Sun FJ, Wu CJ, : p-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J Clin Lab Anal 25:191–197, 2011.
42. Fricke WF, Maddox C, Song Y, Bromberg JS, : Human microbiota characterization in the course of renal transplantation. Am J Transplant 14:416–427, 2014.
43. Lee JR, Muthukumar T, Dadhania D, Toussaint NC, Ling L, Pamer E, Suthanthiran M, : Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation 98:697–705, 2014.
44. Wang W, Xu S, Ren Z, Jiang J, Zheng S, : Gut microbiota and allogeneic transplantation. J Transl Med 13:275, 2015.
45. Rossi M, Johnson DW, Morrison M, Pascoe EM, Coombes JS, Forbes JM, Szeto CC, McWhinney BC, Ungerer JP, Campbell KL, : Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): a randomized trial. Clin J Am Soc Nephrol 11:223–231, 2016.
46. Roberfroid MB, : Prebiotics: preferential substrates for specific germs? Am J Clin Nutr 73(Suppl):406S–409S, 2001.
47. Rossi M, Johnson DW, Xu H, Carrero JJ, Pascoe E, French C, Campbell KL, : Dietary protein–fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients. Nutr Metab Cardiovasc Dis 25:860–865, 2015.
48. Xu H, Rossi M, Campbell KL, Sencion GL, Ärnlöv J, Cederholm T, Sjögren P, Risérus U, Lindholm B, Carrero JJ, : Excess protein intake relative to fiber and cardiovascular events in elderly men with chronic kidney disease. Nutr Metab Cardiovasc Dis 26:597–602, 2016.
49. Salmean YA, Segal MS, Palii SP, Dahl WJ, : Fiber supplementation lowers plasma p-Cresol in chronic kidney disease patients. J Ren Nutr 25:316–320, 2015.
50. Mitu-Pretorian OM, Forgacs B, Qumruddin A, Tavakoli A, Augustine T, Pararajasingam R, : Outcomes of patients who develop symptomatic Clostridium difficile infection after solid organ transplantation. Transplant Proc 42:2631–2633, 2010.
51. Riddle D, Dubberke E, : Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant 13:592–600, 2008.
52. Sidaway P, : Gut microbiota: post-transplant complications associated with gut flora. Nat Rev Nephrol 10:614, 2014.
53. Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A, : Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 33:198–203, 2014.